Complimentary Webinar: Optimizing the Use of Clinical Trial Disclosure Systems
MMS is collaborating with the DIA for an upcoming complimentary webinar, “Optimizing the Use of Clinical Trial Disclosure Systems to Meet Complex and Evolving Global Regulatory Requirements.”
Learning Objectives
- Determine key drivers for the use of technology to manage clinical trial disclosures processes
- Implement efficiencies and consistencies gained from enabling reuse of protocol and results summary content across regions
- Understand the importance of integrating drug and submission-level metrics into disclosures systems
- Identify system features and functionality that are key to achieving global compliance
- Recognize the importance of automated workflow management to manage the disclosures life cycle
Presenters
- Kasim McLain, Manager, Disclosure Services, MMS
- Peggy Zorn, MS, MBA, Associate Director, Regulatory Affairs, Submissions and Transparency, MMS
- Gitta Irmer, MS, Associate Director, Data Quality and Standards, Eisai
- Zach Weingarden, MS, Product Solutions Manager, TrialAssure
Suggested For You
news
September 26th, 2017
Pfizer Selects MMS as Preferred Provider for Plain Language Summary Writing Support

regulatory intelligence
August 9th, 2024
FDA Updates 2024 Language Access Plan

perspectives
May 29th, 2024
Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules
webinar
January 18th, 2024
EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

webinar
January 17th, 2024
EU CTR Compliance and Success: Navigating Updates and Preparing Submissions for the EU CTIS Portal

perspectives
November 7th, 2023
Plain Language Protocol Synopsis – Meeting the EU Regulation

perspectives
October 13th, 2023
EMA Revised Transparency Rules Eliminate the Deferral Mechanism for Clinical Trial Data Publication

perspectives
October 3rd, 2023
Plain Language Summary of Publications: A Key Step To Build Transparency With The Patient Community

perspectives
September 6th, 2023
Relaunch of EMA Policy 0070 in September 2023: The European Medicines Agency’s Revived Commitment to Transparency

perspectives
June 28th, 2023
EMA Policy 0070: Much Awaited Revamp for Clinical Trial Transparency

perspectives
November 30th, 2022
A Step-by-Step Approach to Determining Company Confidential Information (CCI) in Redaction Proposal Packages

perspectives
September 15th, 2022
How does the European Union Clinical Trial Information System (EU-CTIS) Affect Clinical Trial Transparency?